NASDAQ:CBIO

Catalyst Biosciences, Inc Earning Date

USA |NASDAQ |USD

CBIO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.66 $-0.64 $-0.73
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $670.00K $1.13M $893.00K

Catalyst Biosciences, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

CBIO Earnings Date & History Chart

CBIO Earnings & Revenue Forecast

CBIO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.64 $-0.70 $-0.54
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-2.71 $-2.78 $-2.59
Dec 2022 5 $-2.10 $-2.58 $-1.50

CBIO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.64 $-0.64 $-0.73
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.71 $-2.71 $-2.94
Dec 2022 0 / 0 $-2.10 $-2.10 $-2.53

CBIO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $650.00K $0.00 $2.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $4.02M $2.60M $6.40M
Dec 2022 4 $1.25M $0.00 $5.00M

CBIO Earnings Date & Revenue History

CBIO Earnings History

|
Show More
Show More

CBIO Revenue History

|
Show More
Show More

Catalyst Biosciences, Inc Next Earnings Date & Report

CBIO Next Earnings Date & Report Preview: Sep 2021 (FQ)

CBIO's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Catalyst Biosciences, Inc's next quarterly earnings is $-0.66, with a low EPS estimation of $-0.69, and a high estimation of $-0.62.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.66, the last 2 month trend is $-0.66, and the 3 month trend is $-0.72.

Based on 4 analysts, the average revenue estimation is $670.00K, with a low revenue estimation of $0.00, and a high estimation of $1.70M.

Catalyst Biosciences, Inc Previous Earnings Dates & Reports

CBIO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Catalyst Biosciences, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

CBIO's earnings per share (EPS) was $-0.64, beating the consensus analysts forecast of $-0.70 by 8.57%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -18.99%, and higher than the same period a year before (Jun 2020) by -33.33%.

Revenues were $1.13M, better than the forecast of $330.00K by 243.03%, down by -22.84% from the previous quarter , and down by -31.72% from the same period last year.

The company reported a net income of $-19.93M.

Free cash flow for the quarter was $-44.83M , compared to $-24.36M last quarter and $-15.15M a year before.

CBIO ended the quarter with $2.87M in total debt, an increase of 93.26% compared to the previous quarter, and an increase of 83.14% compared to the same quarter a year before.

CBIO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Catalyst Biosciences, Inc's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

CBIO's earnings per share (EPS) was $-2.85, missing the consensus analysts forecast of $-2.70 by 5.56% , and higher than the previous year's EPS (Dec 2019) by -38.04%.

Revenues were $20.95M.

The company reported a net income of $-56.24M.

Catalyst Biosciences, Inc reported a free cash flow of $-55.31M for its fiscal year, compared to $-43.68M a year ago.

The company ended the fiscal year with $1.64M in total debt, a decrease of -8.77% compared to the previous year.